All posts

PlayAGS stock is a Buy in Gaming, says Roth Capital

Roth Capital Partners delivered an update on Wednesday on PlayAGS (PlayAGS Stock Quote, Charts, News, Analysts, Financials NYSE:AGS) after the gaming company released its third quarter earnings this week. Roth analyst Edward Engel reiterated a “Buy” rating on the stock, saying the trend lines look good for AGS to keep its positive momentum going.

Las Vegas-based PlayAGS designs and supplies gaming products and services including electronic gaming machines (EGMs) to the Native American gaming market. The company reported its Q3 on Tuesday, where revenue climbed 16 per cent year-over-year to $78.3 million and adjusted EBITDA was up eight per cent to $34.5 million. (All figures in US dollars.)

“Our third quarter financial results further reflect the people, product and process-driven operating momentum building within our business. Given the encouraging initial customer response to the broader and more diverse new product lineup we recently unveiled at the Global Gaming Expo (G2E), I am even more excited about what lies ahead for our Company and its key stakeholders,” said President and CEO David Lopez in a press release.

The company said its global EGM sales topped 1,000 units over the quarter, which was the first time it hit that height since Q4 2019. EGM revenue per day (RPD) topped $30 for the sixth consecutive quarter. By segment, EGM sales were up 16 per cent to $71.6 million, Table Products was up 30 per cent to $4.0 million and Interactive Games rose by one per cent to $2.6 million.

Looking at the quarterly results, Engel said the Q3 amounted to AGS’ third EBITDA beat this year, with the $78.3 million topline coming in ahead of the consensus estimate at $75.8 million and the adjusted EBTIDA gain of $34.5 million also arriving ahead of the Street’s $33.0 million.

Engel said AGS is delivering better performance and stable costs, which bodes well for earnings growth in 2023. At the same time, the analyst pointed to a need for AGS to continue dealing with its debt before investors will see big gains in the company’s share price.

“AGS ended 3Q with net leverage of 4.0x and expects it below 4x by YE2022. The company has been reducing net leverage by 0.1x each quarter, and we expect a similar trajectory in 2023, which implies net leverage of ~3.5x by YE2023. Given AGS’s 6.5 per cent variable interest rate in 3Q, which is set to increase further in 4Q and potentially beyond, we believe deleveraging will be among the most important drivers to the stock,” Engel said.

With his “Buy” rating, Engel lowered his target price from $12.00 to $10.00, implying a one-year return of 44 per cent.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ags
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

14 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

20 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

21 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

22 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago